Cargando…

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier

Chitosan is a natural polysaccharide, mainly derived from the shell of marine organisms. At present, chitosan has been widely used in the field of biomedicine due to its special characteristics of low toxicity, biocompatibility, biodegradation and low immunogenicity. Chitosan nanoparticles can be ea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiaoyi, Liu, Nan, Wang, Zengming, Gao, Jing, Zhang, Hui, Li, Meng, Du, Yimeng, Gao, Xiang, Zheng, Aiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746444/ https://www.ncbi.nlm.nih.gov/pubmed/35011436 http://dx.doi.org/10.3390/molecules27010204

Ejemplares similares

Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)
por: Wang, Dan, et al.
Publicado: (2021)

Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ
por: Du, Yimeng, et al.
Publicado: (2021)

Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo
por: Di, Jinwei, et al.
Publicado: (2021)

Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
por: Gulati, Neha, et al.
Publicado: (2013)

Preparation of Nanocrystals for Insoluble Drugs by Top-Down Nanotechnology with Improved Solubility and Bioavailability
por: Zhang, Xun, et al.
Publicado: (2020)

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
por: Santos Júnior, Samuel Rodrigues Dos, et al.
Publicado: (2023)

Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review
por: Hua, Yabing, et al.
Publicado: (2021)

Progress in the development of stabilization strategies for nanocrystal preparations
por: Li, Jingru, et al.
Publicado: (2020)

Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines
por: Gong, Xiaochen, et al.
Publicado: (2022)

Innovative color jet 3D printing of levetiracetam personalized paediatric preparations
por: Wang, Zengming, et al.
Publicado: (2021)

Comparison of Paliperidone Palmitate from Different Crystallization Processes and Effect on Formulations In Vitro and In Vivo
por: Shi, Junfeng, et al.
Publicado: (2022)

Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020)

Chitosan Nanoparticles as Oral Drug Carriers
por: Guadarrama-Escobar, Omar Rodrigo, et al.
Publicado: (2023)

Gold nanoparticles with chitosan, N-acylated chitosan, and chitosan oligosaccharide as DNA carriers
por: Abrica-González, Paulina, et al.
Publicado: (2019)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng, Qingqing, et al.
Publicado: (2018)

Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications
por: Gagliardi, Mariacristina, et al.
Publicado: (2023)

Optimizing molecular weight of octyl chitosan as drug carrier for improving tumor therapeutic efficacy
por: Zhang, Min, et al.
Publicado: (2017)

Recent advances of chitosan nanoparticles as drug carriers
por: Wang, Jun Jie, et al.
Publicado: (2011)

Taste Masking Study Based on an Electronic Tongue: the Formulation Design of 3D Printed Levetiracetam Instant-Dissolving Tablets
por: Wang, Zengming, et al.
Publicado: (2021)

Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles–Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung
por: Li, Yumeng, et al.
Publicado: (2019)

Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline
por: Lee, Dong-Won, et al.
Publicado: (2006)

Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
por: Liu, Shanshan, et al.
Publicado: (2018)

Optimizing the design of protein nanoparticles as carriers for vaccine applications
por: Doll, Tais A.P.F., et al.
Publicado: (2015)

Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery
por: Bhattarai, Narayan, et al.
Publicado: (2006)

Preparation of Azithromycin Amorphous Solid Dispersion by Hot-Melt Extrusion: An Advantageous Technology with Taste Masking and Solubilization Effects
por: Li, Jiale, et al.
Publicado: (2022)

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Preparation and characterisation of PHT-loaded chitosan lecithin nanoparticles for intranasal drug delivery to the brain
por: Yousfan, Amal, et al.
Publicado: (2020)

L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
por: Nanaki, Stavroula G., et al.
Publicado: (2022)

New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
por: Popescu, Roxana, et al.
Publicado: (2020)

Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier
por: Li, Qi, et al.
Publicado: (2021)

Curdlan sulfate–O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination
por: Zhang, Shu, et al.
Publicado: (2018)

Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model
por: Rodrigues Dos Santos Junior, Samuel, et al.
Publicado: (2020)

Nanoparticles Based on Chitosan as Carriers for the Combined Herbicides Imazapic and Imazapyr
por: Maruyama, Cintia Rodrigues, et al.
Publicado: (2016)

Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge
por: Zuo, Zonghui, et al.
Publicado: (2021)

Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7
por: Doavi, Tahere, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2022)

Chitosan, Chitosan/IgG-Loaded, and N-Trimethyl Chitosan Chloride Nanoparticles as Potential Adjuvant and Carrier-Delivery Systems
por: Tenorio-Barajas, Aldo Y., et al.
Publicado: (2023)

Key Factor Study for Generic Long-Acting PLGA Microspheres Based on a Reverse Engineering of Vivitrol(®)
por: Hua, Yabing, et al.
Publicado: (2021)

The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions
por: Sun, Wenjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ptg0imuco2dg9u4ohei1kit9cp